Imagine being questioned about complex technical knowledge in front of your peers, supervisors, and members of the ...

Societal expectations can create barriers that prevent men from seeking out the mental, physical, and sexual help they need.

Thousands of men claim finasteride, a drug that many start taking in their 20s and 30s to avoid hair loss, has left them with ...

The makers of Ozempic and Zepbound are fighting to stop compounded copies of their drugs. But it’s unclear whether they can ...

Amazon acquired primary care provider One Medical for $3.9 billion in 2022, and fills prescriptions through Amazon One ...

Hims & Hers Health's stock dropped 25% due to Amazon’s competition. Learn why HIM stock's 38% upside and strong growth make ...

Waystar upped its 2024 outlook and now expects total revenue to range between $926 million and $934 million, compared to ...

The expanded services help customers receive consultations and medications for erectile dysfunction, men’s hair loss, eyelash growth, motion sickness, and anti-aging skin care.

Hims & Hers Health, a telehealth service for clients to access healthcare and prescriptions from home, is seeing its stock ...

Hims & Hers Health Inc. shares tumbled 22% Thursday, on concerns that Amazon.com Inc.'s latest push into healthcare will disrupt Hims & Hers' business.

The announcement is Amazon’s most recent move into the pharmacy space Amazon Amazon continued its move into the pharmacy ...

BofA lowered its rating of Hims & Hers (HIMS) to underperform from buy, citing Amazon’s (AMZN) push into the hair loss and ...